Onkos Surgical® Receives FDA 510(k) Clearance for Application of NanoCept® Antibacterial Technology to Titanium Implants in the ELEOS™ Limb Salvage System
Onkos Surgical® Announces Initiation of 522 Post-Market Surveillance Study of the ELEOS™ Limb Salvage System with NanoCept® Antibacterial Implant Technology
Onkos Surgical® Opens New Innovation Center for NanoCept® Antibacterial Technology
Onkos Surgical® Receives FDA 510(k) Clearance for ELEOS™ Proximal Tibia with NanoCept® Antibacterial Technology
AlloFlo™ Uveo Achieves Key Milestones Ahead of Launch: 7 Peer-Reviewed Studies & 3,000 U.S.Cases
Iantrek Raises $42 Million Series C to Launch AlloFlo™ Uveo, a Breakthrough Interventional Glaucoma Therapy
Iantrek Announces Positive 2-year Results of Efficacy and Safety of its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in Glaucoma Patients
Iantrek Appoints Adam Szaronos as Chief Executive Officer
Horizon Technology Finance Provides $35 Million Venture Loan Facility to Onkos Surgical® to Accelerate Commercialization of Novel Antibacterial Implant Technology
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Iantrek Raises $23M Series B Financing to Advance Next Generation Ophthalmic Micro-Interventional Technologies
Global Healthcare Exchange Enhances Automation, Data Analytics and Inventory Management Capabilities with Acquisition of Syft
Onkos Surgical Raises $15 Million in Series C Funding
Water Street Announces Strategic Investment in Pathnostics
